A PHASE II STUDY OF AMRUBICIN AND CARBOPLATIN FOR PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE-DISEASE SMALL CELL LUNG CANCER

被引：0

作者：

Ikeda, Takaya ^{[1
]}

Taniguchi, Hirokazu ^{[1
]}

Soda, Hiroshi ^{[1
]}

Fukuda, Minoru ^{[2
]}

Kinoshita, Akihito ^{[3
]}

Fukuda, Masaaki ^{[4
]}

Soejima, Yoshifumi ^{[5
]}

Ogawara, Daiki ^{[6
]}

Nakamura, Yoichi ^{[6
]}

Kohno, Shigeru ^{[6
]}

机构：

[1] Sasebo City Gen Hosp, Hirase, Sasebo, Japan

[2] Japanese Red Cross Nagasaki, Isahaya, Nagasaki, Japan

[3] Nagasaki Prefecture Shimabara Hosp, Shimabara, Nagasaki, Japan

[4] Natl Hosp, Org Nagasaki Med Ctr, Omura, Nagasaki, Japan

[5] Ureshino Med Ctr, Ureshina, Japan

[6] Nagasaki Univ Hosp, Dept Internal Med 2, Nagasaki, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷

关键词：

Extensive-Disease Small Cell Lung Cancer; amrubicin; chemotherapy; Carboplatin;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.10-005

引用

页码：S1157 / S1157

页数：1

共 50 条

[31] Irinotecan and etoposide for previously untreated extensive-disease small cell lung cancer: A phase II trial of West Japan Thoracic Oncology Group
Kudoh, S
Nakamura, S
Nakano, T
Komuta, K
Isobe, T
Katakami, N
Fukuda, Y
Takada, Y
Takada, M
Fukuoka, M
Ariyoshi, Y
LUNG CANCER, 2005, 49 (02) : 263 - 269
[32] Phase II study of irinotecan combined with carboplatin in previously untreated small-cell lung cancer
A Kinoshita
M Fukuda
H Soda
S Nagashima
M Fukuda
H Takatani
M Kuba
Y Nakamura
J Tsurutani
S Kohno
M Oka
British Journal of Cancer, 2006, 94 : 1267 - 1271
[33] Phase II study of irinotecan combined with carboplatin in previously untreated small-cell lung cancer
Kinoshita, A
Fukuda, M
Soda, H
Nagashima, S
Fukuda, M
Takatani, H
Kuba, M
Nakamura, Y
Tsurutani, J
Kohno, S
Oka, M
BRITISH JOURNAL OF CANCER, 2006, 94 (09) : 1267 - 1271
[34] PHASE-II STUDY OF VP-16 AND CARBOPLATIN IN PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE SMALL-CELL LUNG-CANCER (SCLC)
EVANS, W
EISENHAUER, E
HUGHES, P
SHEPHERD, F
FELD, R
AYOUB, J
CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1987, 10 (04): : B109 - B109
[35] Phase II study of amrubicin and carboplatin in patients with the refractory or relapsed small cell lung cancer (SCLC).
Hirose, T.
Shirai, T.
Kusumoto, S.
Sugiyama, T.
Yamaoka, T.
Okuda, K.
Ohmori, T.
Ohnishi, T.
Adachi, M.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[36] Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive stage small cell lung cancer (ED-SCLC) (final report).
Ohe, Y
Negoro, S
Matsui, K
Nakagawa, K
Sugiura, T
Takada, Y
Nishiwaki, Y
Saijo, N
Fukuoka, M
Ariyoshi, Y
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 667S - 667S
[37] Phase II study of topotecan and paclitaxel for patients with previously untreated extensive stage small-cell lung cancer
Ramalingam, S
Belani, CP
Day, R
Zamboni, BA
Jacobs, SA
Jett, JR
ANNALS OF ONCOLOGY, 2004, 15 (02) : 247 - 251
[38] Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer
Chen, YM
Wu, MF
Perng, RP
Chou, CM
Yang, KY
Lin, WC
Tsai, CM
Liu, JM
WhangPeng, J
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (02) : 76 - 79
[39] Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer
Fukuda, M
Oka, M
Soda, H
Kinoshita, A
Fukuda, M
Nagashima, S
Kuba, M
Takatani, H
Tsurutani, J
Nakamura, Y
Kasai, T
Inoue, Y
Soejima, Y
Kohno, S
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (06) : 573 - 577
[40] A Phase II/III study comparing carboplatin and irinotecan with carboplatin and etoposide for the treatment of elderly patients with extensive-disease small-cell lung cancer (JCOG1201)
Eba, Junko
Shimokawa, Tsuneo
Nakamura, Kenichi
Shibata, Taro
Misumi, Yuki
Okamoto, Hiroaki
Yamamoto, Noboru
Ohe, Yuichiro
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (01) : 115 - 118

← 1 2 3 4 5 →